» Articles » PMID: 28186225

VALORATE: Fast and Accurate Log-rank Test in Balanced and Unbalanced Comparisons of Survival Curves and Cancer Genomics

Overview
Journal Bioinformatics
Specialty Biology
Date 2017 Feb 11
PMID 28186225
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Summary: The association of genomic alterations to outcomes in cancer is affected by a problem of unbalanced groups generated by the low frequency of alterations. For this, an R package (VALORATE) that estimates the null distribution and the P -value of the log-rank based on a recent reformulation is presented. For a given number of alterations that define the size of survival groups, the log-rank density is estimated by a weighted sum of conditional distributions depending on a co-occurrence term of mutations and events. The estimations are accurately accelerated by sampling across co-occurrences allowing the analysis of large genomic datasets in few minutes. In conclusion, the proposed VALORATE R package is a valuable tool for survival analysis.

Availability And Implementation: The R package is available in CRAN at https://cran.r-project.org and in http://bioinformatica.mty.itesm.mx/valorateR .

Contact: vtrevino@itesm.mx.

Supplementary Information: Supplementary data are available at Bioinformatics online.

Citing Articles

Systematic Modeling of Risk-Associated Copy Number Alterations in Cancer.

Guardado A, Aguirre-Gamboa R, Trevino V Int J Mol Sci. 2024; 25(19).

PMID: 39408785 PMC: 11477427. DOI: 10.3390/ijms251910455.


The Impact of Mutational Hotspots on Cancer Survival.

Gonzalez-Cardenas M, Trevino V Cancers (Basel). 2024; 16(5).

PMID: 38473427 PMC: 10931094. DOI: 10.3390/cancers16051072.


Heterozygous Knockout of Using CRISPR/Cas9 Attenuates Some Aggressive Phenotypes in a Breast Cancer Cell Line.

Gonzalez-Salinas F, Herrera-Gamboa J, Rojo R, Trevino V Genes (Basel). 2023; 14(12).

PMID: 38137006 PMC: 10743217. DOI: 10.3390/genes14122184.


Establishment and validation of a prognostic nomogram based on a novel five-DNA methylation signature for survival in endometrial cancer patients.

Li X, Yin F, Fan Y, Cheng Y, Dong Y, Zhou J Cancer Med. 2020; 10(2):693-708.

PMID: 33350104 PMC: 7877372. DOI: 10.1002/cam4.3576.


Downregulation of orosomucoid 2 acts as a prognostic factor associated with cancer-promoting pathways in liver cancer.

Zhu H, Zhou W, Wan Y, Ge K, Lu J, Jia C World J Gastroenterol. 2020; 26(8):804-817.

PMID: 32148378 PMC: 7052533. DOI: 10.3748/wjg.v26.i8.804.